BiotechTube
Home/Abpro/Robert Markelewicz, MD
RM

Robert Markelewicz, MD

Chief Medical Officer

Abpro

Therapeutic Areas

Oncology

Abpro Pipeline

DrugIndicationPhase
ABP-102 / CT-P72HER2-positive cancersPreclinical

Leadership Team at Abpro

MS
Miles Suk
CEO, Chairman
View full Abpro profile